BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6137333)

  • 1. Metabolism, distribution, and excretion of the carcinogenic aromatic amine, 3,3'-dimethoxybenzidine in the rat. Formation of mutagenic urinary and biliary metabolites.
    Rodgers RM; Garvie-Gould C; Scott KF; Milam DF; Lynn RK
    Drug Metab Dispos; 1983; 11(4):293-300. PubMed ID: 6137333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of the aromatic amine, benzidine, in the rat: characterization of mutagenic urinary and biliary metabolites.
    Lynn RK; Garvie-Gould CT; Milam DF; Scott KF; Eastman CL; Ilias AM; Rodgers RM
    Toxicol Appl Pharmacol; 1984 Jan; 72(1):1-14. PubMed ID: 6710475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-mediated bacterial mutagenesis and enterohepatic circulation of benzidine-derived mutagenic metabolites in rodents.
    Chipman JK; Mohn GR
    Xenobiotica; 1989 Jan; 19(1):43-50. PubMed ID: 2667260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of benzo(f)quinoline in male rats.
    Birnbaum LS; Johnson L
    Drug Metab Dispos; 1985; 13(1):18-24. PubMed ID: 2858371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of the flame retardant, tris(1,3-dichloro-2-propyl) phosphate, in the rat.
    Lynn RK; Wong K; Garvie-Gould C; Kennish JM
    Drug Metab Dispos; 1981; 9(5):434-41. PubMed ID: 6117442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the human carcinogen, benzidine, in the isolated perfused rat liver.
    Lynn RK; Garvie-Gould C; Milam DF; Scott KF; Eastman CL; Rodgers RM
    Drug Metab Dispos; 1983; 11(2):109-14. PubMed ID: 6133713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism, disposition, and mutagenicity of 2,6-diaminotoluene, a mutagenic noncarcinogen.
    Cunningham ML; Burka LT; Matthews HB
    Drug Metab Dispos; 1989; 17(6):612-7. PubMed ID: 2575496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution, excretion, and metabolism of butylbenzyl phthalate in the rat.
    Eigenberg DA; Bozigian HP; Carter DE; Sipes IG
    J Toxicol Environ Health; 1986; 17(4):445-56. PubMed ID: 3959124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excretion and biotransformation of cisapride in rats after oral administration.
    Meuldermans W; Hendrickx J; Lauwers W; Hurkmans R; Mostmans E; Swysen E; Bracke J; Knaeps A; Heykants J
    Drug Metab Dispos; 1988; 16(3):410-9. PubMed ID: 2900733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and disposition of n-butyl acrylate in male Fischer rats.
    Sanders JM; Burka LT; Matthews HB
    Drug Metab Dispos; 1988; 16(3):429-34. PubMed ID: 2900736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.
    Meuldermans W; Hendrickx J; Lauwers W; Hurkmans R; Swysen E; Thijssen J; Timmerman P; Woestenborghs R; Heykants J
    Drug Metab Dispos; 1987; 15(6):905-13. PubMed ID: 2893720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
    Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
    Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.
    Denissen JF; Grabowski BA; Johnson MK; Boyd SA; Uchic JT; Stein H; Cepa S; Hill P
    Drug Metab Dispos; 1994; 22(6):880-8. PubMed ID: 7895605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of urinary metabolites of ecabapide in rat.
    Fujimaki Y; Hosokami T; Ono K
    Xenobiotica; 1995 May; 25(5):501-10. PubMed ID: 7571723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
    Timchalk C; Smith FA; Bartels MJ
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic disposition of [14C]pivhydrazine, [14C]mebanazine, and [14C]benzylhydrazine in the rat.
    Bolton GC; Griffiths LA
    Drug Metab Dispos; 1979; 7(6):388-92. PubMed ID: 43225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of aminoglutethimide in the rat.
    Egger H; Bartlett F; Itterly W; Rodebaugh R; Shimanskas C
    Drug Metab Dispos; 1982; 10(4):405-12. PubMed ID: 6126342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolism of methiothepin in the rat, dog and man].
    Eschenhof E; Meister W; Oesterhelt G; Vetter W
    Arzneimittelforschung; 1976 Feb; 26(2):262-71. PubMed ID: 947211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.